» Articles » PMID: 38331839

Analysis of Differences in Intestinal Flora Associated with Different BMI Status in Colorectal Cancer Patients

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2024 Feb 8
PMID 38331839
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Overweight is known to be an important risk factor for colorectal cancer (CRC), and the differences in intestinal flora among CRC patients with different BMI status have not been clearly defined. The purpose of this study was to elucidate the differences in the abundance, composition and biological function of intestinal flora in CRC patients with different BMI status.

Method: A total of 170 CRC patients were included and grouped according to the BMI data of CRC patients. BMI ≥ 24 kg/m was defined as overweight group, and BMI within the range of 18.5-23.9 kg/m was defined as normal weight group. Preoperative stool collection of patients in both groups was used for 16S rRNA sequencing. Total RNA was extracted from 17 CRC tumor tissue samples for transcriptome sequencing, and then CIBERSORT algorithm was used to convert the transcriptome data into the relative content matrix of 22 kinds of immune cells, and the correlation between different intestinal flora and immune cells and immune-related genes under different BMI states was analyzed. Finally, we identified BMI-related differential functional pathways and analyzed the correlation between these pathways and differential intestinal flora.

Result: There was no significant difference in α diversity and β diversity analysis between overweight group and normal weight group. Partial least square discriminant analysis (PLS-DA) could divide the flora into two different clusters according to BMI stratification. A total of 33 BMI-related differential flora were identified by linear discriminant effect size analysis (LEfSe), among which Actinomyces, Desulfovibrio and Bacteroides were significantly enriched in overweight group. ko00514: Other types of O-glycan biosynthesis are significantly enriched in overweight group. There was a significant positive correlation between Clostridium IV and Macrophages M2 and T cells regulatory (Tregs). There was a significant negative correlation with Dendritic cells activated and T cells CD4 memory activated.

Conclusions: The richness and diversity of intestinal flora of CRC patients may be related to different BMI status, and the enrichment of Actinomyces, Desulphurvibrio and Bacteroides may be related to overweight status of CRC patients. The tumor microenvironment in which BMI-related differential flora resides has different immune landscapes, suggesting that some intestinal flora may affect the biological process of CRC by regulating immune cell infiltration and immune gene expression, but further experiments are needed to confirm this.

Citing Articles

Multiomics insights into BMI-related intratumoral microbiota in gastric cancer.

Liu K, Jiang Z, Ma Y, Xia R, Zheng Y, Yin K Front Cell Infect Microbiol. 2025; 15:1511900.

PMID: 40041144 PMC: 11876552. DOI: 10.3389/fcimb.2025.1511900.


The global burden of colorectal cancer attributable to high body-mass index in 204 countries and territories: findings from 1990 to 2021 and predictions to 2035.

Jin X, Dong D, Xu Z, Sun M Front Nutr. 2024; 11:1473851.

PMID: 39634543 PMC: 11614609. DOI: 10.3389/fnut.2024.1473851.


Intestinal nanoparticle delivery and cellular response: a review of the bidirectional nanoparticle-cell interplay in mucosa based on physiochemical properties.

Wang Y, Mo Y, Sun Y, Li J, An Y, Feng N J Nanobiotechnology. 2024; 22(1):669.

PMID: 39487532 PMC: 11531169. DOI: 10.1186/s12951-024-02930-6.


Exploring the gut microbiome's role in colorectal cancer: diagnostic and prognostic implications.

Chen G, Ren Q, Zhong Z, Li Q, Huang Z, Zhang C Front Immunol. 2024; 15:1431747.

PMID: 39483461 PMC: 11524876. DOI: 10.3389/fimmu.2024.1431747.


Effects of Polyvinyl Chloride Microplastics on the Reproductive System, Intestinal Structure, and Microflora in Male and Female Mice.

Yang Y, Ge S, Su Q, Chen J, Wu J, Kang K Vet Sci. 2024; 11(10).

PMID: 39453080 PMC: 11512291. DOI: 10.3390/vetsci11100488.

References
1.
Tang Q, Jin G, Wang G, Liu T, Liu X, Wang B . Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices. Front Cell Infect Microbiol. 2020; 10:151. PMC: 7161087. DOI: 10.3389/fcimb.2020.00151. View

2.
Robb C, Kour S, Contreras J, Agarwal E, Barger C, Rana S . Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 2018; 9(4):5216-5232. PMC: 5797045. DOI: 10.18632/oncotarget.23749. View

3.
Wong S, Yu J . Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019; 16(11):690-704. DOI: 10.1038/s41575-019-0209-8. View

4.
Kordahi M, Stanaway I, Avril M, Chac D, Blanc M, Ross B . Genomic and functional characterization of a mucosal symbiont involved in early-stage colorectal cancer. Cell Host Microbe. 2021; 29(10):1589-1598.e6. PMC: 8979638. DOI: 10.1016/j.chom.2021.08.013. View

5.
Hanzelmann S, Castelo R, Guinney J . GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013; 14:7. PMC: 3618321. DOI: 10.1186/1471-2105-14-7. View